text:
EX-99.1
2
ex_128964.htm
EXHIBIT 99.1
ex_128964.htm
Exhibit 99.1
Quest Contacts
Kim Gorode (Media): 973-520-2800
Shawn Bevec (Investors): 973-520-2900
Oxford Immunotec
Global
Contact:
Karen Koski (Investors & Media), 508-556-1377 or kkoski@oxfordimmunotec.com
Quest Diagnostics Completes Acquisition of
U.S.
Laboratory Services
Business of
Oxford Immunotec
Oxford Immunotec
's
T-SPOT
®
.
TB
T
uberculosis
and Accutix™
T
ick-
B
orne
D
isease
T
esting
Services
are
Part of Quest
Diagnostics
'
Portfolio of Innovative Infectious Disease Diagnostics Tests
,
Broadening Access in the United States
SECAUCUS
, NJ, OXFORD, England and MARLBOROUGH, Mass.
-
November
6,
201
8
- Quest Diagnostics (NYSE: DGX) and Oxford Immunotec Global PLC (Nasdaq: OXFD) today announced that Quest Diagnostics has completed its previously announced acquisition of the U.S. laboratory services business of Oxford Immunotec.
The T-SPOT.
TB
tuberculosis and the Accutix tick-borne disease testing services are now part of Quest Diagnostics' portfolio of innovative infectious disease testing services. As part of the transaction, Oxford Immunotec will sell T-SPOT.
TB
test kits and related accessories to Quest Diagnostics under the terms of a long-term supply agreement. In addition, the parties have entered into a strategic collaboration agreement to drive continued growth of T-SPOT.
TB
testing in the U.S.
Quest Diagnostics intends to continue to offer QuantiFERON TB testing services to provide physicians choice in blood-based TB testing.
About Blood-
B
ased TB Testing
The T-SPOT.
TB
test is an interferon-gamma release assay (IGRA) that is intended for use as an aid in the diagnosis of
Mycobacterium tuberculosis
infection and disease. As many as 13 million cases of latent TB may exist in the U.S.
i
The Infectious Diseases Society of America (IDSA) and other medical associations recommend blood-based IGRA TB testing over traditional skin testing for certain patient populations, citing relative accuracy and the ability to perform IGRA testing with one office visit.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
www.QuestDiagnostics.com
.
Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.
About Oxford Immunotec
Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions. The Company's T-SPOT.
TB
test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, U.K. and in Marlborough, MA. Additional information can be found at
www.oxfordimmunotec.com
.
T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.
Forward-Looking Statements
This release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this release are forward-looking statements. This includes statements about Oxford Immunotec's anticipated plans, objectives, intentions, the anticipated benefits of the transaction, the effects of the transaction, including effects on future financial and operating results, prospects for sales of its products and other statements that are not historical facts. Actual events or results may differ materially from those described in this release due to a number of risks and uncertainties. Risks and uncertainties include, among others: the potential disruption of management time from ongoing business operations due to the transaction; the risk that Oxford Immunotec may fail to realize the expected benefits from the transaction; the risk that the announcement of the completion of the transaction could have adverse effects on the market price of Oxford Immunotec's ordinary shares; decisions by regulatory authorities, hospitals and other health care institutions, laboratories, physicians, patients and third party payers that could affect Oxford Immunotec's business and prospects; Oxford Immunotec's exposure to potential litigation and contingent liabilities pursuant to the transaction; as well as Oxford Immunotec's ability to expeditiously and successfully expand its sales and distribution networks. The risks included above are not exhaustive. Other factors that could adversely affect Oxford Immunotec's business and prospects are described under the "Risk Factors" section in its filings with the Securities and Exchange Commission ("SEC"). Oxford Immunotec's SEC filings are available for free by visiting the investor section of its website,
www.oxfordimmunotec.com
, or the SEC's website,
www.sec.gov
.
Investors should give careful consideration to these risks and uncertainties. Forward-looking statements contained herein are based on current expectations and assumptions and currently available data and are neither predictions nor guarantees of future events or performance. You should not place undue reliance on forward-looking statements contained herein, which speak only as of the date of this release. Oxford Immunotec does not undertake to update or revise any forward-looking statements after they are made, whether as a result of new information, future events, or otherwise, except as required by applicable law.
i
https://labtestsonline.org/news/blood-tests-recommended-over-skin-tests-to-check-for-tb-in-most-cases

text: Oxford Immunotec

text: Quest Diagnostics

text: Oxford Immunotec

text: Oxford Immunotec

text:
Quest
Diagnostics

text: Quest Diagnostics

text: Oxford Immunotec

text: Quest Diagnostics

text: Oxford Immunotec

text: Quest Diagnostics

text: Oxford Immunotec

text: Quest Diagnostics

text: Quest Diagnostics

text: Quest Diagnostics

text: Quest Diagnostics

text: Quest Diagnostics

text: Quest Diagnostics

text: Quest Diagnostics

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec

text: Oxford Immunotec


dataset: buster

text:
EX-99.1
3
ex991to8k11776012_10012020.htm
Exhibit 99.1
Hudson Global Acquires Coit Group
Significantly Expands
Hudson RPO's Tech Sector and West Coast Presence
Establishes Office in San
Francisco
OLD GREENWICH, CT, October 1, 2020
- Hudson
Global, Inc. (the "Company" or "Hudson RPO") (Nasdaq: HSON), a leading global total talent solutions company,
announced today the acquisition of Coit Group ("Coit"), a San Francisco-based RPO provider.
Founded 20 years ago by Joe Belluomini and Tim
Farrelly, Coit is an RPO provider specializing in procuring top talent for high-growth companies, predominately in the San Francisco
Bay Area. With this acquisition, Hudson RPO significantly expands its presence in the technology sector and establishes an office
in San Francisco. In addition, Joe Belluomini and Tim Farrelly will become co-CEOs of Hudson RPO's newly-formed Technology
Group. The Technology Group will operate jointly with Hudson RPO's existing teams in the Americas, Asia Pacific, and EMEA
regions to grow Hudson RPO's service offering to technology clients. The Technology Group will also provide continuous access
to knowledge regarding new and emerging technologies in the RPO, MSP, and Total Talent Solutions space so Hudson RPO can better
serve all of its clients around the world.
"Our RPO model was significantly influenced
by Hudson RPO, which makes this combination a natural fit. We are very excited about Hudson RPO's strong reputation and global
reach, as well as what we can do together for our clients. We are very happy to become part of the Hudson RPO team", said
Mr. Belluomini, CEO of Coit.
"This transaction represents a significant
achievement for the Coit team and is a testament to the team's dedication and performance. We believe our long history of
providing excellent service to companies in the Bay Area combined with Hudson RPO's global market position creates an exciting
growth opportunity to meet the global talent needs of our clients", said Mr. Farrelly, President of Coit.
"We are thrilled to welcome the Coit team
to Hudson RPO and believe this accretive combination will generate considerable value for our clients, team, and stockholders going
forward", said Jeff Eberwein, Chief Executive Officer of the Company. "The addition of Coit significantly expands Hudson
RPO's presence in the technology sector and on the West Coast. Hudson RPO now has an office in the San Francisco/Silicon
Valley region staffed with a talented team which, combined with Hudson RPO's global delivery capability, positions us well
to serve the global growth ambitions of companies located in this thriving region".
About Hudson RPO
Hudson Global, Inc. is a leading total
talent solutions provider operating under the brand name Hudson RPO. We deliver innovative, customized recruitment outsourcing
and total talent solutions to organizations worldwide. Through our consultative approach, we design tailored solutions to meet
our clients' strategic growth initiatives. As a trusted advisor, we meet our commitments, deliver quality and value, and
strive to always exceed expectations.
For more information, please visit
us at
hudsonrpo.com
or contact us at
ir@hudsonrpo.com
.
Investor Relations:
The Equity Group
Lena Cati
212 836-9611
lcati@equityny.com
About Coit Group
Coit Group works with top talent to build winning
teams for high-growth companies. Our knowledgeable, friendly, and results-driven recruiters carefully screen candidates to ensure
they are an exceptional match for the position, team personalities, and unique company culture long before they meet with the client.
Please visit
coitgroup.com
for more information.
Forward-Looking Statements
This press release contains statements
that the company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements
regarding the company's future financial condition, results of operations, business operations and business prospects, are forward-looking
statements. Words such as "anticipate", "estimate", "expect", "project", "intend,"
"plan", "predict", "believe" and similar words, expressions and variations of these words and expressions
are intended to identify forward-looking statements. All forward-looking statements are subject to important factors, risks, uncertainties,
and assumptions, including industry and economic conditions that could cause actual results to differ materially from those described
in the forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to, global economic
fluctuations; the adverse impacts of the recent coronavirus, or COVID-19 outbreak; the Company's ability to successfully
achieve its strategic initiatives; risks related to the Company's large cash balance relative to its market capitalization
as a small public company; risks related to potential acquisitions or dispositions of businesses by the Company; the Company's
ability to retain and recruit qualified management and/or advisors; the Company's ability to operate successfully as a company
focused on its RPO business; risks related to fluctuations in the Company's operating results from quarter to quarter; the ability
of clients to terminate their relationship with the Company at any time; competition in the Company's markets; the negative cash
flows and operating losses that may recur in the future; risks relating to how future credit facilities may affect or restrict
our operating flexibility; risks associated with the Company's investment strategy; risks related to international operations,
including foreign currency fluctuations, political events, natural disasters or health crises, including the ongoing COVID-19 outbreak;
the Company's dependence on key management personnel; the Company's ability to attract and retain highly skilled professionals;
the Company's ability to collect accounts receivable; the Company's ability to maintain costs at an acceptable level; the
Company's heavy reliance on information systems and the impact of potentially losing or failing to develop technology; risks related
to providing uninterrupted service to clients; the Company's exposure to employment-related claims from clients, employers and
regulatory authorities, current and former employees in connection with the Company's business reorganization initiatives,
and limits on related insurance coverage; the Company's ability to utilize net operating loss carry-forwards; volatility
of the Company's stock price; the impact of government regulations; and restrictions imposed by blocking arrangements. Additional
information concerning these, and other factors is contained in the Company's filings with the Securities and Exchange Commission.
These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims
any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

label: organization

text: Hudson Global

text: Coit Group

text: Hudson RPO

text:
Hudson
Global, Inc.

text: Hudson RPO

text: Coit Group

text: Coit

text: Coit

text: Hudson

text: Hudson RPO

text: Hudson RPO

text: Hudson RPO

text: Hudson RPO

text: Hudson RPO

text: Hudson RPO

text: Hudson RPO

text: Coit

text: Coit

text: Hudson RPO

text: Coit

text: Coit

text: Hudson RPO

label: person

text: Jeff Eberwein

text: Coit

text:
Hudson
RPO

text: Hudson RPO

text: Hudson RPO

text: Hudson RPO

text: Hudson Global, Inc.

text: Hudson RPO

text: Coit Group

text: Coit Group

source_dataset: expertai/BUSTER

annotation_scope: BUSTER company-role spans plus reviewed organization, fund, person, and event additions with document-local surface projection; annotations remain non-exhaustive


text:
EX-99.1
2
ex99-1.htm
EXHIBIT 99.1
ex99-1.htm
Exhibit
99.1
Southern Connecticut Bancorp,
Inc
.
Press
Release
For
More Information Contact:
John H.
Howland
Executive
Vice President & Chief Operating Officer
(203)
782-1100
Southern Connecticut
Bancorp, Inc. Completes Sale of New London Branch
New
Haven, Connecticut
(March 6,
2008) - Southern Connecticut Bancorp, Inc. (AMEX:SSE),
the holding
company for The Bank of Southern Connecticut announced today the completion of
the sale of its branch known as The Bank of Southeastern Connecticut, a division
of The Bank of Southern Connecticut located in New London,
Connecticut. The branch was purchased by Savings Institute Bank and
Trust Company, a wholly-owned subsidiary of SI Financial Group, Inc. (NASDAQ
Global Market: SIFI).
The sale
of this branch is part of an overall profitability enhancement program and
expense saving initiative instituted by the Board of Directors and Management of
the Company. The Bank of Southern Connecticut plans to use the
proceeds from this transaction to support its operations in the greater New
Haven market.
About Southern Connecticut Bancorp,
Inc.
Southern
Connecticut Bancorp, Inc. is a commercial bank holding company dedicated to
serving the banking needs of businesses located in the greater New Haven
area. Southern Connecticut Bancorp owns 100% of The Bank of Southern
Connecticut, headquartered in New Haven Connecticut. The Bank of
Southern Connecticut is a provider of commercial banking services to a client
base of small to midsized companies with annual sales typically ranging from
$1,000,000 to $30,000,000. The Bank's services include a wide range
of deposit, loan and other basic commercial banking products along with a
variety of consumer banking products. The Bank currently operates
four branches, two in New Haven, Connecticut, one in Branford, Connecticut
and one in North Haven, Connecticut.
Certain
statements contained in this release and in other written materials and
statements we may issue, including without limitation statements containing the
word "believes", "anticipates", "intends", "expects", "estimates", "could",
"would", "will", or words of similar import, constitute forward-looking
statements within the meaning of the federal securities laws.
Such
forward-looking statements involve risks, uncertainties and other factors that
may cause our actual future results, performance or achievements to be
materially different from any future results expressed or implied by such
forward-looking statements. Such factors include, among others, a limited
operating history and volatility of earnings, our dependence on our executive
management and Board of Directors, our business concentration in small to
midsized businesses in the New Haven, Connecticut area, as well as changes in
our business, competitive market and regulatory conditions and strategies.
Additional information concerning factors that could impact forward-looking
statements can be found in the company's periodic public filings with the
Securities and Exchange Commission. Given these uncertainties,
readers are cautioned not to place any undue reliance on such forward-looking
statements. We disclaim any intent or obligation to update these forward-looking
statements to reflect facts, assumptions, circumstances or events that occur
after the date on which such forward-looking statements were made.

text: Bancorp, Inc.

text: Southern Connecticut Bancorp, Inc.

text: The Bank of Southeastern Connecticut

text: SI Financial Group, Inc.

text:
Southern Connecticut Bancorp,
Inc.

text:
Southern
Connecticut Bancorp, Inc.


text:
EX-99.1
4
ex_138216.htm
EXHIBIT 99.1
ex_138216.htm
Exhibit 99.1
Tucows Inc. Acquires Wholesale Domain Registrar Ascio Technologies
-- European registrar brings incremental scale, additional domain products and a high-quality reseller base to Tucows' domains business --
TORONTO, March 19, 2019 - Tucows Inc. (NASDAQ:TCX, TSX:TC), a provider of network access, domain names and other Internet services, announced that it has signed a definitive agreement to acquire wholesale domain name registrar Ascio Technologies from CSC®. The transaction closed yesterday.
Tucows will pay $29.44 million and the transaction is expected to be immediately accretive to operating cash flow. The purchase price will be funded through Tucows' existing credit facility.
The acquisition of Ascio adds approximately 1.8 million domains under management and approximately 500 active resellers. The Ascio reseller base fits squarely with Tucows' core customer profile -- ISPs, web hosting companies and website builders serving quality businesses that reward outstanding customer service with long-term loyalty.
Ascio also expands Tucows' product portfolio with one of the most complete offerings of country code TLDs (ccTLDs) and generic TLDs (gTLDs) in the world.
Jørgen Christensen, Managing Director of Ascio commented, "This deal is all about focus. We wanted to find a buyer who would focus on our resellers so that CSC can focus on managing brands for the biggest and best companies around the world".
"This acquisition makes perfect sense for Ascio's resellers, our business and our shareholders", added David Woroch, Tucows' Executive Vice President of Domains. "Ascio's resellers get a customer-focused provider that is investing in its wholesale channel. Tucows gets an excellent business with a deeply experienced team, additional domain products, including more than 50 ccTLDs, and a high-quality customer base that strengthens our European presence. And our shareholders get the benefit of Tucows' even greater scale and efficiency as the world's largest wholesale domain registrar".
The contribution from this transaction, based on a partial year and transaction costs, was contemplated in the 2019 guidance provided by Tucows on February 13, 2019. Pre-acquisition, the Ascio business generated approximately $4 million of annual EBITDA. Tucows is required to apply acquisition accounting to the assets and liabilities acquired, including fair valuation of the acquired deferred revenue balance, which will lower the reported Adjusted EBITDA
1
contribution in the first approximately one year period following the acquisition. The acquisition is expected to provide synergies over the next 12 to 18 months which, along with the inclusion of full year financial results, is expected to generate an internal rate of return and multiple that are in line with Company benchmarks.
About Ascio
Ascio Technologies was founded in 1999, and is an accredited domain registrar under the Internet Corporation for Assigned Names and Numbers with approximately 1.8 million domains under management. Ascio is a part of the family of brands under CSC.
About CSC
CSC is the world's leading provider of business, legal, tax, and digital brand services to companies around the globe. From keeping businesses in compliance and streamlining operations, to protecting and promoting brands online, CSC uses its expertise and personal approach to help businesses run smoother. CSC is the business behind business. It is the trusted partner for 90% of the Fortune 500®, more than 65% of the Best Global Brands (Interbrand®), nearly 10,000 law firms, and more than 3,000 financial organizations. Headquartered in Wilmington, Delaware, USA, since 1899, CSC has offices throughout the United States, Canada, Europe, and the Asia-Pacific region. CSC is a global company capable of doing business wherever its clients are-and it accomplishes that by employing experts in every business it serves. Learn more at
https://www.cscglobal.com
.
About Tucows
Tucows is a provider of network access, domain names and other Internet services. Ting (
https://ting.com
) delivers mobile phone service and fixed Internet access with outstanding customer support. OpenSRS (
http://opensrs.com
) and Enom (
http://www.enom.com
) manage a combined 23 million domain names and millions of value-added services through a global reseller network of over 37,000 web hosts and ISPs. Hover (
http://hover.com
) makes it easy for individuals and small businesses to manage their domain names and email addresses. More information can be found on Tucows' corporate website (
http://tucows.com
).
Tucows, Ting, OpenSRS, Enom and Hover are registered trademarks of Tucows Inc. or its subsidiaries.
Notes:
1. Adjusted EBITDA
Tucows reports all financial information required in accordance with United States generally accepted accounting principles (GAAP). Along with this information, to assist financial statement users in an assessment of our historical performance, the Company typically discloses and discusses a non-GAAP financial measure, adjusted EBITDA, in press releases and on investor conference calls and related events that exclude certain non-cash and other charges as the Company believes that the non-GAAP information enhances investors' overall understanding of our financial performance.
The Company believes that the provision of this supplemental non-GAAP measure allows investors to evaluate the operational and financial performance of the Company's core business using similar evaluation measures to those used by management. The Company uses adjusted EBITDA to measure its performance and prepare its budgets. Since adjusted EBITDA is a non-GAAP financial performance measure, the Company's calculation of adjusted EBITDA may not be comparable to other similarly titled measures of other companies; and should not be considered in isolation, as a substitute for, or superior to measures of financial performance prepared in accordance with GAAP. Because adjusted EBITDA is calculated before recurring cash charges, including interest expense and taxes, and is not adjusted for capital expenditures or other recurring cash requirements of the business, it should not be considered as a liquidity measure. Non-GAAP financial measures do not reflect a comprehensive system of accounting and may differ from non-GAAP financial measures with the same or similar captions that are used by other companies and/or analysts and may differ from period to period. The Company endeavors to compensate for these limitations by providing the relevant disclosure of the items excluded in the calculation of adjusted EBITDA to net income based on U.S. GAAP, which should be considered when evaluating the Company's results. Tucows strongly encourages investors to review its financial information in its entirety and not to rely on a single financial measure.
The Company's adjusted EBITDA definition excludes depreciation, amortization of intangible assets, income tax provision, interest expense, interest income, stock-based compensation, asset impairment, gains and losses from unrealized foreign currency transactions and infrequently occurring items, including acquisition and transition costs. Gains and losses from unrealized foreign currency transactions removes the unrealized effect of the change in the mark-to-market values on outstanding unhedged foreign currency contracts, as well as the unrealized effect from the translation of monetary accounts denominated in non-U.S. dollars to U.S. dollars.
Contact:
Lawrence Chamberlain
Loderock Advisors
(416) 519-4196
lawrence.chamberlain@loderockadvisors.com

text: Tucows Inc.

text: Ascio Technologies

text: Tucows

text: Tucows Inc.

text: Ascio Technologies

text: Tucows

text: Tucows

text: Ascio

text: Ascio

text: Tucows

text: Ascio

text: Tucows

text: Jørgen Christensen

text: Ascio

text: Ascio

text: Tucows

text: Ascio

text: Tucows

text: Tucows

text: Tucows

text: Ascio

text: Tucows

text: Ascio

text: Ascio Technologies

text: Ascio

text: Tucows

text: Tucows

text: Tucows

text: Tucows

text: Tucows Inc.

text: Tucows

text: Tucows


text:
EX-99.1
2
tm201748d1_ex99-1.htm
EXHIBIT 99.1
Exhibit
99.1
Press Release
FOR IMMEDIATE RELEASE
Contact:
Lynda L. Glass
EVP/Secretary &
Chief Governance Officer
717.339.5085
lglass@acnb.com
ACNB
Corporation announceS Completion
of
the acquisition of FREDERICK COUNTY BANCORP, inc.
GETTYSBURG, PA, January 13,
2020 --- ACNB Corporation (NASDAQ: ACNB), the parent financial holding company of ACNB Bank, a Pennsylvania
state-chartered, FDIC-insured community bank, headquartered in Gettysburg, PA, announced the completion of the acquisition of
Frederick County Bancorp, Inc. (OTCPink: FCBI) ("FCBI") and its wholly-owned subsidiary, Frederick County Bank,
headquartered in Frederick, MD, effective January 11, 2020. FCBI was merged with and into a wholly-owned subsidiary of ACNB
Corporation immediately followed by the merger of Frederick County Bank with and into ACNB Bank. ACNB Bank will operate in
the Frederick County, MD, market as "FCB Bank, A Division of ACNB Bank".
Under the terms
of the Reorganization Agreement, FCBI stockholders received 0.9900 share of ACNB Corporation common stock for each share of FCBI
common stock that they owned as of the closing date. As a result, ACNB Corporation issued approximately 1,600,000 shares of its
common stock and cash in exchange for fractional shares based upon $36.43, the determined market share price of ACNB Corporation
common stock in accordance with the Reorganization Agreement.
In
addition, pursuant to the Reorganization Agreement, former FCBI director Kimberly S. Chaney was appointed as a Class 3
Director to ACNB Corporation's Board of Directors and as Director to ACNB Bank's Board of Directors. Ms. Chaney, the former
chairman of the FCBI board of directors, has been a CPA for over 30
ACNB CORPORATION
Press Release/ACNB Corporation Announces Completion
of the Acquisition of Frederick County Bancorp, Inc.
January 13, 2020
Page
2
of
3
years and owns an accounting practice specializing in financial services and consulting for small businesses
in Frederick, MD.
With the
combination of the two organizations, ACNB Corporation, on a consolidated basis, has approximately $2.2 billion in assets, $1.8 billion
in deposits, and $1.6 billion in loans with 34 community banking offices and three loan offices located in the counties of
Adams, Cumberland, Franklin, Lancaster and York in Pennsylvania and the counties of Baltimore, Carroll and Frederick in
Maryland.
"We are excited
to welcome Frederick County Bancorp, Inc. as ACNB Corporation expands its presence in the Maryland market", stated ACNB Corporation
President & Chief Executive Officer James P. Helt. "Frederick is a growing, vibrant market for community banking, which
is at the core of ACNB Corporation's success for more than 160 years. It is our belief the addition of Frederick County Bank's
community banking network in Frederick County, Maryland, positions ACNB Corporation for strong and profitable growth in a desirable
market that is adjacent to our current footprint in southcentral Pennsylvania and central Maryland".
He continued, "Strategically,
this acquisition is intended to complement our existing operations, while contributing to the Corporation's established tradition
of enhancing long-term shareholder value. As a result of the acquisition, Kimberly S. Chaney joins the Boards of Directors of ACNB
Corporation and ACNB Bank. Her knowledge of the Frederick market will prove valuable in the successful execution of our long-term
strategic plan".
Bybel
Rutledge LLP served as legal counsel and Boenning & Scattergood, Inc. served as financial advisor to ACNB Corporation.
Buckley LLP served as legal counsel and Sandler O'Neill + Partners, LP served as financial advisor to Frederick County
Bancorp, Inc.
ACNB Corporation,
headquartered in Gettysburg, PA, is the financial holding company for the wholly-owned subsidiaries of ACNB Bank, Gettysburg,
PA, and Russell Insurance Group, Inc., Westminster, MD. Originally founded in 1857, ACNB Bank serves its marketplace with banking
and wealth
ACNB CORPORATION
Press Release/ACNB Corporation Announces Completion
of the Acquisition of Frederick County Bancorp, Inc.
January 13, 2020
Page
3
of
3
management
services, including trust and retail brokerage, via a network of 22 community banking offices, located in the four
southcentral Pennsylvania counties of Adams, Cumberland, Franklin and York, as well as loan offices in Lancaster and York,
PA, and Hunt Valley, MD. As divisions of ACNB Bank operating in Maryland, FCB Bank and NWSB Bank serve the local marketplace via a
network of five and seven community banking offices located in Frederick County and Carroll County, MD, respectively. Russell
Insurance Group, Inc., the Corporation's insurance subsidiary, is a full-service agency with licenses in 44 states. The
agency offers a broad range of property, casualty, health, life and disability insurance serving personal and commercial
clients through office locations in Westminster, Germantown and Jarrettsville, MD. For more information regarding ACNB
Corporation and its subsidiaries, please visit acnb.com.
# # #
FORWARD-LOOKING STATEMENTS - In addition
to historical information, this press release may contain forward-looking statements. Examples of forward-looking statements include,
but are not limited to, (a) projections or statements regarding future earnings, expenses, net interest income, other income, earnings
or loss per share, asset mix and quality, growth prospects, capital structure, and other financial terms, (b) statements of plans
and objectives of management or the Board of Directors, and (c) statements of assumptions, such as economic conditions in the Corporation's
market areas. Such forward-looking statements can be identified by the use of forward-looking terminology such as "believes",
"expects", "may", "intends", "will", "should", "anticipates",
or the negative of any of the foregoing or other variations thereon or comparable terminology, or by discussion of strategy. Forward-looking
statements are subject to certain risks and uncertainties such as local economic conditions, competitive factors, and regulatory
limitations. Actual results may differ materially from those projected in the forward-looking statements. Such risks, uncertainties
and other factors that could cause actual results and experience to differ from those projected include, but are not limited to,
the following: the effects of governmental and fiscal policies, as well as legislative and regulatory changes; the effects of new
laws and regulations, specifically the impact of the Tax Cuts and Jobs Act and the Dodd-Frank Wall Street Reform and Consumer Protection
Act; impacts of the capital and liquidity requirements of the Basel III standards; the effects of changes in accounting policies
and practices, as may be adopted by the regulatory agencies, as well as the Financial Accounting Standards Board and other accounting
standard setters; ineffectiveness of the business strategy due to changes in current or future market conditions; future actions
or inactions of the United States government, including the effects of short- and long-term federal budget and tax negotiations
and a failure to increase the government debt limit or a prolonged shutdown of the federal government; the effects of economic
conditions on current customers, specifically the effect of the economy on loan customers' ability to repay loans; the effects
of competition, and of changes in laws and regulations on competition, including industry consolidation and development of competing
financial products and services; the risks of changes in interest rates on the level and composition of deposits, loan demand,
and the values of loan collateral, securities, and interest rate protection agreements, as well as interest rate risks; difficulties
in acquisitions and integrating and operating acquired business operations, including information technology difficulties; challenges
in establishing and maintaining operations in new markets; the effects of technology changes; volatilities in the securities markets;
the effect of general economic conditions and more specifically in the Corporation's market area; the failure of assumptions
underlying the establishment of reserves for loan losses and estimations of values of collateral and various financial assets and
liabilities; acts of war or terrorism; disruption of credit and equity markets; the ability to manage current levels of impaired
assets; the loss of certain key officers; the ability to maintain the value and image of the Corporation's brand and protect
the Corporation's intellectual property rights; continued relationships with major customers; and, potential impacts to the
Corporation from continually evolving cybersecurity and other technological risks and attacks, including additional costs, reputational
damage, regulatory penalties, and financial losses. We caution readers not to place undue reliance on these forward-looking statements.
They only reflect management's analysis as of this date. The Corporation does not revise or update these forward-looking
statements to reflect events or changed circumstances. Please carefully review the risk factors described in other documents the
Corporation files from time to time with the SEC, including the Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.
Please also carefully review any Current Reports on Form 8-K filed by the Corporation with the SEC.
ACNB #2020-1
January 13, 2020

text:
ACNB
Corporation

text: FREDERICK COUNTY BANCORP, inc.

text: ACNB Corporation

text: ACNB

text: ACNB

text: Frederick County Bancorp, Inc.

text: FCBI

text: FCBI

text: FCBI

text: ACNB

text: ACNB

text: ACNB

text: ACNB

text: FCBI

text: ACNB Corporation

text: FCBI

text: ACNB Corporation

text: ACNB Corporation

text: FCBI

text: ACNB Corporation

text: ACNB

text: FCBI

text: ACNB CORPORATION

text: ACNB Corporation

text: Frederick County Bancorp, Inc.

text: ACNB Corporation

text: Frederick County Bancorp, Inc.

text: ACNB Corporation

text: ACNB Corporation

text: ACNB Corporation

text: ACNB Corporation

text:
ACNB
Corporation

text: ACNB

text:
Bybel
Rutledge LLP

text: Boenning & Scattergood, Inc.

text: ACNB Corporation

text: Buckley LLP

text: Sandler O'Neill + Partners, LP

override: organization

text:
Frederick County
Bancorp, Inc.

text: ACNB Corporation

text: ACNB

text: ACNB

text: ACNB CORPORATION

text: ACNB Corporation

text: Frederick County Bancorp, Inc.

text: ACNB

text:
ACNB
Corporation

text: ACNB


text:
EX-99.1
2
v070999_ex99-1.htm
Unassociated Document
FOR
IMMEDIATE RELEASE:
FAMILYMEDS
COMMENCES SALE OF PHARMACY ASSETS TO WALGREEN CO.
FARMINGTON,
CT, April 5, 2007 -- Familymeds Group, Inc. (OTCBB: FMRX), a specialty pharmacy
and medical specialty product provider, today announced that it began selling
its pharmacy assets to Walgreen Co. and Walgreen Eastern Co., pursuant to the
asset purchase agreement dated February 14, 2007. Familymeds' shareholders
approved the asset sale to Walgreens at its special shareholder meeting held
last week at the Company's Farmington offices.
The
asset
purchase agreement is for the sale of up to 53 Familymeds locations, operating
under the Familymeds and Arrow Pharmacy and Nutrition Center brands to
Walgreens. In consideration, Walgreens will pay approximately $60 million for
pharmacy assets, customer accounts receivable and inventories for these
locations, subject to adjustment based on closing physical inventory counts.
The
majority of the locations sold will remain open and continue to operate in
place; the remainder will have files and business transferred to a nearby
Walgreens location. The Company expects to complete the sale to Walgreens during
the second quarter of 2007.
Ed
Mercadante, Chairman & CEO of Familymeds commented, "Our management team and
Walgreens are working together to ensure the smoothest transition possible
for
our customers without any interruption in service." Mr. Mercadante further
commented, "It has been a pleasure working with Walgreens executives during this
process. Walgreens has offered positions to, and welcomed, most of our store
associates, ensuring not only a familiar presence to our customers, but also
avoiding disruption to our staff during this sale".
Familymeds
also announced today that it has completed several smaller asset deals for
certain pharmacy locations, and is continuing in its discussions with other
national and regional pharmacy operators to pursue additional opportunities
in
the coming weeks. The overall plan includes distribution of the proceeds of
the
Walgreens sale and such other sales to its shareholders following repayment
of
debt, satisfaction of certain liabilities and associated Company costs.
About
Familymeds Group, Inc.
Familymeds
Group, Inc. is a pharmacy and medical specialty product provider formed by
the
merger on November 12, 2004 of DrugMax, Inc. and Familymeds Group, Inc.
Familymeds works closely with doctors, patients, managed care providers, medical
centers and employers to improve patient outcomes while delivering low cost
and
effective healthcare solutions. Familymeds now operates 68 locations, including
7 franchised locations, in 13 states under the Familymeds Pharmacy and Arrow
Pharmacy & Nutrition Center brand names; most of the locations in New
England area operate under the Arrow Pharmacy brand. The Company also operates
Worksite Pharmacy(SM), which provides solutions for major employer groups.
The
Company also operates Familymeds Medical Specialty a specialty pharmaceutical
distribution business directly to physicians and other healthcare providers.
The
overall Familymeds business platform is designed to provide pharmaceutical
services for the treatment of acute and complex health diseases including
chronic medical conditions such as cancer, diabetes and pain management. More
information can be found at http://www.familymedsgroup.com. The Company's online
product offering can be found at http://www.familymeds.com.
About
Walgreen Company
Walgreen
Co. (NYSE, NASDAQ: WAG) is the nation's largest drugstore chain with fiscal
2006
sales of $47.4 billion. The company operates 5,675 stores in 48 states and
Puerto Rico, including 76 Happy Harry's drugstores in Delaware and surrounding
states. Walgreens also provides additional services to pharmacy patients and
prescription drug and medical plans through Walgreens Health Services, its
managed care division, which includes Walgreens Health Initiatives Inc. (a
pharmacy benefits manager), Walgreens Mail Service Inc., Walgreens Home Care
Inc. and Walgreens Specialty Pharmacy.
Safe
Harbor Provisions
Certain
oral statements made by management from time to time and certain statements
contained in press releases and periodic reports issued by Familymeds Group,
Inc., including those contained herein, that are not historical facts are
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Because such statements involve risks and
uncertainties, actual results may differ materially from those expressed or
implied by such forward-looking statements. Forward-looking statements are
statements regarding the intent, belief or current expectations, estimates
or
projections of the Company, its directors or its officers about the Company
and
the industry in which it operates. Although Familymeds Group, Inc. believes
that
its expectations are based on reasonable assumptions, it can give no assurance
that the anticipated results will occur. When used in this report, the words
"expects", "anticipates", "intends", "plans", "believes", "seeks", "estimates,"
and similar expressions are generally intended to identify forward-looking
statements. Important factors that could cause the actual results to differ
materially from those in the forward-looking statements include, among other
items, management's ability to successfully implement additional asset sale,
liquidation and dissolution plans, the ability of Familymeds Group, Inc. to
comply with its obligations under agreements governing indebtedness or obtain
waivers from lenders in the event of non-compliance, the continued availability
of liquidity and capital resources required to complete these transactions,
particularly in the event that such transactions require more time than
management anticipates, and other factors. Familymeds Group, Inc. disclaims
any
intention or obligation to update or revise forward-looking statements, whether
as a result of new information, future events or otherwise.
Contact:
Cindy
Berenson, Familymeds Group, Inc.
860.676.1222
x138; berenson@familymeds.com
SOURCE
Familymeds Group, Inc.
#
#
#

text: FAMILYMEDS

text: WALGREEN CO.

text: Familymeds

text: Walgreen Co.

text: Walgreen Eastern Co.

text: Familymeds

text: Familymeds

text: Familymeds

text:
Ed
Mercadante

text: Familymeds

text: Familymeds

text: Familymeds

text: Familymeds

text: Familymeds

text: Familymeds

text: Familymeds

text: Familymeds

text: Familymeds

text: Familymeds

text:
Walgreen
Co.

text: Familymeds

text: Familymeds

text: Familymeds

text: Familymeds

text: Familymeds

text: Familymeds


text:
EX-99
2
ex99-1.htm
EX. 99.1: PRESS RELEASE
Exhibit 99.1
COMPANY CONTACT:
AT FINANCIAL RELATIONS BOARD:
James Mead
Leslie Loyet
Tim Grace
Chief Financial Officer
Analyst Inquiries
Media Inquiries
(312) 658-5740
(312) 640-6672
(312) 640-6667
FOR IMMEDIATE RELEASE
TUESDAY, AUGUST 8, 2006
STRATEGIC HOTELS & RESORTS CLOSES ON ACQUISITION OF PARTNER'S INTEREST IN INTERCONTINENTAL HOTEL IN PRAGUE
Chicago, IL - August 8, 2006 - Strategic Hotels & Resorts, Inc. (NYSE: BEE)
today announced that the company closed on its acquisition of a 65.0% interest in the entity that owns the InterContinental Hotel in Prague, Czech Republic, for $68.8 million, from affiliates of GIC Real Estate, Inc. The purchase brings the company's interest in the entity that owns the property to 100%. Including the assumption of $56.5 million in debt, the company's total investment to acquire the 65% interest is $125.3 million.
About the Company
Strategic Hotels & Resorts, Inc. is a real estate investment trust (REIT) which owns and asset manages high-end hotels and resorts. The company has ownership interests in 19 properties with an aggregate of 9,607 rooms. For further information, please visit the company's website at http://www.strategichotels.com.
###

text: Tim Grace

text: Strategic Hotels & Resorts, Inc.

text: GIC Real Estate, Inc

text: Strategic Hotels & Resorts, Inc.


text:
EX-99.1
2
v383421_ex99-1.htm
EXHIBIT 99.1
Corporate Headquarters
712 Fifth Avenue
New York, NY 10019
877.826.BLUE (2583)
www.bluerockresidential.com
PRESS RELEASE
For Immediate Release
BRG Closes Investment in Alexan CityCentre,
a 340-Unit Class A Development in Houston; Announces Trammell Crow Residential as Development Partner
New York, NY (July 8, 2014)
-
Bluerock Residential Growth REIT, Inc. (NYSE MKT: BRG) ("BRG" or "the Company") announced today that it
has made a convertible preferred equity investment in a joint venture with Trammell Crow Residential ("TCR"), which
was formed to develop a Class A rental apartment community known as Alexan CityCentre. Sized at approximately 340 units, the development
is centrally located within the Houston, Texas Energy Corridor submarket, adjacent to CityCentre, a prominent 37-acre mixed use
development complex encompassing 1.8 million square feet of office, hotel, retail, and residential space.
BRG's underwriting projects a trended
return on cost for the project of over 7.0% at stabilization, for value creation of 200 to 250 basis points versus sales of comparable
multifamily communities in the Houston, Texas area at 4.5% - 5.0%, the Company said. The investment is forecast to generate a
15% AFFO yield during the development phase.
BRG expects to invest approximately $6.5
million of preferred equity, and together with affiliates of Bluerock Real Estate LLC, will contribute approximately 90% of the
required equity for the development, with the balance contributed by TCR. Once the project is developed and 70% leased, BRG will
have a right to convert its preferred equity investment into a control-position common membership interest in the managing member
of the joint venture. Pending exercise of this conversion right, BRG will be entitled to a current-pay preferred return on its
investment of 15% per year.
"TCR is a premier developer and a
preferred builder in major markets across the country, with a track record of delivering measurable value, both strategic and operational,
to the developments with which it is associated. We are extremely pleased to be able to work with them to bring this project to
life", said Ramin Kamfar, Chairman and CEO of BRG.
Alexan CityCentre will be situated in close
commuting proximity to two West Houston employment nodes: the Energy Corridor, which houses 20.3 million square feet of office
space and a reported 84,000 employees, as well as the Westchase District, which has approximately 14.3 million square feet of office
space and 82,000 employees. Companies within these employment centers include BP America, Citgo, ConocoPhillips, Dow Chemical,
ExxonMobil Chemical, Shell Oil Exploration and Production, Sysco and WorleyParsons, among others.
To attract the high income demographic
working in the Energy Corridor and Westchase District, and to best leverage its location, the venture plans to build product that
is considered high end for the submarket, featuring approximately 277 one-bedroom units and approximately 63 two-bedroom units,
averaging 829 square feet. In addition to premium finishes and appliances, the complex will feature high-quality community amenities
such as a resort quality pool, state of the art fitness facility, concierge, and business center.
The foregoing items were addressed and
disclosed by the Company in a Current Report on Form 8-K filed on July 8, 2014 with the Securities and Exchange Commission.
About Bluerock Residential Growth REIT,
Inc.
Bluerock Residential Growth REIT, Inc.
(NYSE MKT: BRG) is a real estate investment trust formed to acquire a diversified portfolio of institutional-quality apartment
properties in demographically attractive growth markets throughout the United States. The Company has elected to be taxed as a
real estate investment trust (REIT) for U.S. federal income tax purposes.
About Trammell Crow Residential
Trammell Crow Residential ("TCR")
is a premier multifamily real estate firm whose entities develop, construct and acquire multifamily communities of the highest
standard. TCR owns approximately 16,000 apartment units nationwide, with an additional 5,000 new units under construction or planned
to begin in 2014. TCR has been in business for more than three decades, and has developed more than 225,000 multifamily units
in most major markets across the country.
Forward Looking Statements
This press
release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other
federal securities laws. Forward looking statements are statements that are not historical, including statements regarding management's
intentions, beliefs, expectations, representations, plans or predictions of the future, and are typically identified by such words
as "believe", "expect", "anticipate", "intend", "estimate", "may,"
"will", "should" and "could." Because such statements include risks, uncertainties and contingencies,
actual results may differ materially from those expressed or implied by such forward looking statements. These forward looking
statements are based upon the Company's present expectations, but these statements are not guaranteed to occur, including
the property's ability to attract target renters, management's commentary regarding Trammell Crow's track record,
and the attractiveness and implied value of the property. Furthermore, the Company disclaims any obligation to publicly update
or revise any forward-looking statement to reflect changes in underlying assumptions or factors, of new information, data or methods,
future events or other changes. Investors should not place undue reliance upon forward looking statements. For further discussion
of the factors that could affect outcomes, please refer to discussions of risk factors as detailed in filings by the Company with
the Securities and Exchange Commission ("SEC"), including our periodic reports. We claim the safe harbor protection
for forward looking statements contained in the Private Securities Litigation Reform Act of 1995.
Contact
(Media)
Josh Hoffman
(208) 475.2380
jhoffman@bluerockre.com
##

text: BRG

text: Alexan CityCentre

text: Trammell Crow Residential

text: Bluerock Residential Growth REIT, Inc.

text: BRG

text: BRG

text: Trammell Crow Residential

text: Alexan CityCentre

text: BRG

text: BRG

text: Bluerock Real Estate LLC

text: BRG

text: BRG

text: Ramin Kamfar

text: BRG

text: Alexan CityCentre

text:
Bluerock Residential Growth REIT,
Inc.

text: Bluerock Residential Growth REIT, Inc.

text: BRG

text: Trammell Crow Residential

text: Trammell Crow Residential


text:
EX-99.1
2
exhibit991chitranche2press.htm
EXHIBIT 99.1
Exhibit
Exhibit 99.1
PRESS RELEASE
Contact:
Physicians Realty Trust
John T. Thomas
President and CEO
(214) 549-6611
jtt@docreit.com
Jeffrey N. Theiler
Executive Vice President and CFO
(414) 367-5610
jnt@docreit.com
Physicians Realty Trust Announces Closing of the
Second Tranche of the Catholic Health Initiatives Acquisition
Announces Record $691 Million of Medical Facility Investments
Completed in Second Quarter 2016
CHI Acquisition Highlights:
.
The Second Tranche of the Catholic Health Initiatives (CHI) Acquisition includes 20 medical office facilities totaling 1,421,500 rentable square feet
.
4 additional medical office facilities under executed Purchase and Sale Agreements to be acquired from CHI in the third quarter of 2016, resulting in a final acquired portfolio of 50 properties
.
2 properties representing approximately $13 million of investment were removed during the due diligence process
Milwaukee, WI - July 5, 2016 - Physicians Realty Trust (NYSE: DOC) (the "Company", the "Trust", "we", "our" and "us"), a self-managed healthcare real estate investment trust, today announced that it has closed the second tranche of its previously announced pending purchase of medical office facilities from Catholic Health Initiatives ("CHI"). The closing of the second tranche, completed between June 2nd and June 30th, included 20 medical office facilities for a purchase price of approximately $305 million. Including the previously announced closing of tranche one, the Company's total investment in CHI affiliated properties acquired to date totals $628 million.
John T. Thomas, President and Chief Executive Officer of the Trust, commented, "We have worked closely with our colleagues at Catholic Health Initiatives (CHI) to complete almost all of our investment in these CHI mission-critical medical office buildings. With only a handful of properties left, we are very pleased with the pace at which we have been able to complete this investment for the benefit of our shareholders and to help CHI further their clinical care mission. Except for one project that is currently under construction, we expect the closing of the remainder of the portfolio to occur early in the third quarter of 2016, with all of the previously announced CHI affiliated acquisitions to be completed by the end of the third quarter, but we cannot provide any assurance that these follow-on acquisitions will be completed".
Thomas added, "Beyond the CHI investments, we completed several additional acquisitions this quarter, as summarized below. These were primarily off-market acquisitions of facilities leased to or affiliated with existing healthcare system clients. Of note, we have already been able to capitalize on our newly formed CHI relationship with these additional acquisitions, by purchasing a 100% CHI-leased connecting building of one of our KentuckyOne CHI assets in Louisville, KY directly from its physician owners".
Thomas concluded, "This is by far the largest quarter for investments by Physicians Realty Trust. As we approach our third anniversary this month, we are very pleased with the growth and quality of cash flow we have produced for our shareholders. The stable foundation we have built includes more than $2.5 billion in real estate assets, containing approximately 10 million square feet, with industry-leading occupancy. We look forward to sharing more details with our second quarter earnings and filings".
Investment Update
In addition to the CHI Acquisitions detailed above, the Company has completed acquisitions of 6 healthcare properties containing an aggregate of 165,625 net rentable square feet since our May 5, 2016 press release. These investments total approximately $43.5 million. The Company also entered into one mezzanine loan for $1.3 million.
About Physicians Realty Trust
Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare. The Company conducts its business through an UPREIT structure in which its properties are owned by Physicians Realty L.P., a Delaware limited partnership (the "operating partnership"), directly or through limited partnerships, limited liability companies or other subsidiaries. The Company is the sole general partner of the operating partnership and, as of March 31, 2016, owned approximately 96.5% of the partnership interests in our operating partnership ("OP Units").
Investors are encouraged to visit the Investor Relations portion of the Company's website (www.docreit.com) for additional information, including annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, press releases, supplemental information packages and investor presentations.
Forward-Looking Statements
This press release contains statements that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate", "believe", "expect", "estimate", "plan", "outlook", and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward looking statements may include statements regarding the Company's strategic and operational plans, the Company's ability to generate internal and external growth, the future outlook, anticipated cash returns, cap rates or yields on properties, anticipated closing of property acquisitions, and ability to execute its business plan. While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. Forward looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward looking statements are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward looking statements. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company's control, which could cause actual results to differ materially from such statements. These risks and uncertainties are described in greater detail in the Company's filings with the Securities and Exchange Commission (the "Commission"), including, without limitation, the Company's annual and periodic reports and other documents filed with the Commission. Unless legally required, the Company disclaims any obligation to update any forward-looking statements after the date of this release, whether as a result of new information, future events or otherwise. For a description of factors that may cause the Company's actual results or performance to differ from its forward-looking statements, please review the information under the heading "Risk Factors" included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015 filed by the Company with the Commission on February 29, 2016.
Source: Physicians Realty Trust

text: Physicians Realty Trust

text: John T. Thomas

text: Physicians Realty Trust

text: Catholic Health Initiatives

text: Catholic Health Initiatives

text: Physicians Realty Trust

text: Catholic Health Initiatives

text: John T. Thomas

text: Catholic Health Initiatives

text: Physicians Realty Trust

text: Physicians Realty Trust

text: Physicians Realty Trust

text: Physicians Realty Trust


text:
EX-99.1
2
dp15144_ex9901.htm
EXHIBIT 99.1
Exhibit
99.1
Press
Release
PartnerRe Ltd.
Announces Successful Closing of Block Purchase of PARIS RE Shares Bringing Total
Ownership to 83%
PEMBROKE,
Bermuda--(BUSINESS WIRE)--Oct. 4, 2009-- PartnerRe Ltd. (NYSE:PRE) today
announced the successful closing of its previously announced block purchase of
common shares of PARIS RE Holdings Limited (Euronext:PRI), the French-listed,
Swiss-based diversified reinsurer. As of the close of business on October 2,
2009, PartnerRe had acquired in the block purchase approximately 71% of the
outstanding PARIS RE shares, with an additional 6% of the outstanding PARIS RE
shares subject to physical settlement in the coming days. Following the
settlement of these trades, PartnerRe's total shareholding of PARIS RE will
increase to 83%, which includes PartnerRe's previously announced acquisition of
6% of the outstanding PARIS RE shares.
PartnerRe President
& CEO Patrick Thiele said, "The closing of this block purchase is an
important milestone in our acquisition of PARIS RE. With this level of
ownership, we take control of the PARIS RE Board of Directors through the
appointment of six directors, all of whom are existing PartnerRe management.
This Board majority allows us a greater role in setting policy and monitoring
risk aggregation. However, there is no change in our strategy for January 1,
2010 renewals; the companies will renew their business separately, under their
current plans and guidelines".
Mr. Thiele added,
"The acquisition process has gone more quickly and smoothly than was initially
anticipated and we are optimistic that the remaining steps will be completed by
year-end. This is due in no small part to the hard work and cooperation shown by
the employees of both organizations".
As
recently announced, PartnerRe will pursue a merger vote in lieu of a voluntary
exchange offer, which is expected to expedite PartnerRe's acquisition of PARIS
RE, while keeping unchanged the consideration granted to PARIS RE
shareholders.
PartnerRe also
announced that in closing the block purchase, it has received all necessary
approvals of insurance and competition regulatory authorities. It is expected
that PARIS RE will call a meeting of its shareholders to vote on a proposal to
effect a merger, governed by Swiss law, of PARIS RE into a wholly-owned
subsidiary of PartnerRe. The merger, when approved by the holders of at least
90% of all outstanding PARIS RE voting rights, is expected to become effective
in December 2009.
PartnerRe
is a leading global reinsurer, providing multi-line reinsurance to insurance
companies. The Company through its wholly owned subsidiaries also offers
alternative risk products that include weather and credit protection to
financial, industrial and service companies. Risks reinsured include property,
casualty, motor, agriculture, aviation/space, catastrophe, credit/surety,
engineering, energy, marine, specialty property, specialty casualty, other
lines, life/annuity and health, and alternative risk products. For the year
ended December 31, 2008, total revenues were $4.0 billion. At June 30, 2009,
total assets were $17.0 billion, total capital was $5.3 billion and total
shareholders' equity was $4.8 billion.
PartnerRe
on the Internet:
www.partnerre.com
Forward-looking
statements contained in this press release are based on the Company's
assumptions and expectations concerning future events and financial performance
and are made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Such statements are subject to significant
business, economic and competitive risks and uncertainties that could cause
actual results to differ materially from those reflected in the forward-looking
statements. PartnerRe's forward-looking statements could be affected by numerous
foreseeable and unforeseeable events and developments such as exposure to
catastrophe, or other large property and casualty losses, adequacy of reserves,
risks associated with implementing business strategies and integrating new
acquisitions, levels and pricing of new and renewal business achieved, credit,
interest, currency and other risks associated with the Company's, PARIS RE's, or
the combined company's investment portfolio, changes in accounting policies, the
risk that a condition to the closing of the proposed transaction with PARIS RE
may not be satisfied, the risk that a regulatory approval that may be required
for the proposed transaction is not obtained or is obtained subject to
conditions that are not anticipated, failure to consummate or delay in
consummating the proposed transaction for other reasons, and other factors
identified in the Company's filings with the Securities and Exchange Commission.
In light of the significant uncertainties inherent in the forward-looking
information contained herein, readers are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the dates on which
they are made. The Company disclaims any obligation to publicly update or revise
any forward-looking information or statements.
Source: PartnerRe
Ltd.
PartnerRe
Ltd.
Investor: Robin
Sidders, 441-292-0888
or
Media: Celia
Powell, 441-292-0888
or
Sard
Verbinnen & Co.
Drew Brown/Jane
Simmons, 212-687-8080
The information on
this and any other page of the PartnerRe web site is provided subject to the
terms of our User Agreement and Disclaimer which is accessed by clicking the
link at the bottom of this page.
Copyright
2009

text: PartnerRe Ltd.

text: PARIS RE

text: PartnerRe Ltd.

text: PARIS RE Holdings Limited

text: PartnerRe

text: PARIS RE

text: PARIS RE

text: PartnerRe

text: PARIS RE

text: PartnerRe

text: PARIS RE

text: PartnerRe

text: PARIS RE

text: PARIS RE

text: PartnerRe

text: PartnerRe

text: PartnerRe

text:
PARIS
RE

text: PARIS RE

text: PartnerRe

text: PARIS RE

text: PARIS RE

text: PartnerRe

text: PARIS RE

text: PartnerRe

text: PartnerRe

text: PartnerRe

text: PARIS RE

text: PARIS RE

text:
PartnerRe
Ltd.

text:
PartnerRe
Ltd.

text: PartnerRe


text:
EX-99.1
2
f8k013120ex99-1_advansource.htm
PRESS RELEASE DATED FEBRUARY 3, 2020
Exhibit 99.1
AdvanSource
Biomaterials Corporation Announces Completion of the Sale of Substantially All of its Assets to a Subsidiary of Mitsubishi Chemical
America
WILMINGTON,
Mass, Feb. 03, 2020 (GLOBE NEWSWIRE) --
AdvanSource Biomaterials Corporation (OTC: ASNB) ("AdvanSource"
or the "Company"), a materials technology company specializing in medical grade polymers for long and short term applications,
announced today that on Friday, January 31, 2020, substantially all of its assets were sold to Mitsubishi Chemical Performance
Polymers, Inc. ("Mitsubishi Chemical Performance Polymers" or "MCPP"). As previously announced,
AdvanSource entered into an Asset Purchase Agreement with MCPP, a subsidiary of Mitsubishi Chemical America, Inc. and its shareholder,
Mitsubishi Chemical Corporation, to sell substantially all of its assets to Mitsubishi Chemical Performance Polymers for a price
of $7.25 million in cash (the "Transaction").
"The
successful completion of this transaction offers our shareholders a meaningful premium", said Michael Adams, CEO of AdvanSource.
"We anticipate issuing a shareholder dividend in the near future".
The
description of the Transaction contained herein is only a summary and is qualified in its entirety by reference to the Asset Purchase
Agreement relating to the Transaction, a copy of which was filed by AdvanSource with the Securities and Exchange Commission (the
"SEC") as an exhibit to a Current Report on Form 8-K filed on December 2, 2019.
About
AdvanSource
AdvanSource
develops advanced polymer materials which provide critical characteristics in the design and development of medical devices. Its
biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states. Its business
model leverages proprietary materials science technology and manufacturing expertise in order to expand product sales and royalty
and license fee income.
AdvanSource's
technology, notably products such as ChronoFlex®, HydroMed™, and HydroThane™, have been developed to overcome
a wide range of design and functional challenges, such as the need for dimensional stability, ease of manufacture and demanding
physical properties to overcoming environmental stress cracking and providing heightened lubricity for ease of insertion. AdvanSource's
new product extensions customize proprietary polymers for specific customer applications in a wide range of device categories.
About
Mitsubishi Chemical Performance Polymers
Mitsubishi
Chemical Performance Polymers, Inc. is a specialty chemical company and direct subsidiary of Mitsubishi Chemical America, Inc.,
the regional headquarters in North America of Mitsubishi Chemical Corporation. The Mitsubishi Chemical group of companies operates
over 350 affiliates in more than 30 countries, with annual revenue in excess of $24 billion. Leveraging its affiliates'
manufacturing capabilities and expertise in R&D, sales, and marketing, MCPP seeks to innovate in compounding polymerization
and polymer modification technologies for the 21st century, with a view towards sustainability practices in a circular economy.
MCPP
operates facilities in Bellevue, Ohio, Warren, Michigan, Greer, South Carolina, and Brazil. MCPP's product portfolio includes:
Tefabloc™, Thermorun™, Trexprene™ and Zelas™ thermoplastic elastomers; Modic™ functional polyolefins;
Linklon™ cross-linked polyolefins; Olefista™ non-halogenated fire retardant polyolefins; Marfyflo™, Sunprene™,
and Vinika™ polyvinylchloride elastomers; and BIOPBS™, DURABIO™, and Forzeas™ bio-sustainable thermoplastic
resins.
MCPP's
products and expertise are used in a wide variety of specialized commercial applications in the packaging, construction, wire
& cable, consumer, medical, 3d printing, and automotive industries.
Advisor
and Counsel
In
connection with this transaction, Mirus Securities is acting as financial advisor and Ellenoff Grossman & Schole LLP is acting
as legal advisor to AdvanSource. Winston & Strawn LLP is acting as legal advisor to Mitsubishi Chemical Performance Polymers.
Cautionary
Note Regarding Forward-Looking Statements
Some of the statements in this release are or may constitute "forward-looking
statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.
Actual results may differ from expectations, estimates and projections presented or implied and, consequently, you should not
rely on these forward-looking statements as predictions of future events. Words such as "believe", "expect,"
"anticipate", "project", "target", "optimistic", "intend", "aim,"
"will", "may" and variations and similar words and expressions are intended to identify such forward-looking
statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements relating
to the Transaction include, but are not limited to: (i) statements about the benefits of the Transaction; (ii) Mitsubishi Chemical
Performance Polymers' plans, objectives, expectations and intentions; and (iii) the expected timing of a post-closing dividend.
Forward-looking statements involve estimates, expectations and projections and, as a result, are subject to risks and uncertainties,
many of which are beyond AdvanSource's control. Actual results could differ materially if not substantially from those
described in the forward-looking statements.
2
Important
risks and other factors could cause actual results to differ materially from those indicated by such forward-looking statements.
With respect to the Transaction, such risks and uncertainties include, among many others: (i) the risk that the benefits to AdvanSource
and its stockholders anticipated from Transaction may not be fully realized or may take longer to realize than expected; (ii)
the outcome of any legal proceedings related to the Transaction; or (iii) any of the factors in detailed in the "Risk Factors"
section of AdvanSource's filings with the SEC.
The
foregoing listing of risks is not exhaustive. These risks, as well as other risks associated with the Transaction, are more
fully discussed in AdvanSource's definitive proxy statement in connection with the transaction, which was filed with the SEC on
December 31, 2019 (the "Proxy Statement"). Additional risks and uncertainties are identified and discussed in AdvanSource's
reports filed or to be filed with the SEC, including its Form 10-K, as amended, for the fiscal year ended December 31, 2018, and
the Proxy Statement, and are available at the SEC's website at http://www.sec.gov. Forward-looking statements included in
this press release speak only as of the date of this press release. AdvanSource undertakes and assumes no obligation, and
does not intend, to update AdvanSource's forward-looking statements, except as required by law.
Contacts
AdvanSource
Biomaterials Corporation
Michael F. Adams
President and Chief Executive Officer
978-657-0075
Ext 156
3

text:
AdvanSource
Biomaterials Corporation

text: Mitsubishi Chemical

text: AdvanSource Biomaterials Corporation

text: AdvanSource

text: MCPP

text: AdvanSource

text: MCPP

text: Mitsubishi Chemical

text: Mitsubishi Chemical

text: Michael Adams

text: AdvanSource

text: AdvanSource

text: AdvanSource

text: AdvanSource

text: AdvanSource

text: AdvanSource

text: Mitsubishi Chemical

text: Mitsubishi Chemical

text: Mitsubishi Chemical

text: MCPP

text: MCPP

text: MCPP

text: MCPP

text: Mirus Securities

text: Ellenoff Grossman & Schole LLP is

text: AdvanSource

text: Winston & Strawn LLP

text: AdvanSource

text: AdvanSource

text: AdvanSource

text: AdvanSource

text: AdvanSource

text: AdvanSource

text: AdvanSource

text:
AdvanSource
Biomaterials Corporation

text: Michael F. Adams


text:
EX-99.1
3
ex99-1.htm
News
Release
Investor
Contacts:
Andrew
Gibson
Edison
Group
taronis@edisongroup.com
Taronis
Acquires Los Angeles-Based Industrial Gas Distributor
Taronis
Adds $4.5 Million in Annual Revenue, now a Top Five Player in the Two
Largest Metal Cutting Fuel Markets in the US
TAMPA,
FL - February 26, 2019 - Taronis Technologies, Inc. ("Taronis" or "the Company") (NASDAQ:
TRNX), a leading clean technology company in the renewable resources and environmental conservation industry, today announced
that the Company has completed the acquisition of one of the largest independently owned industrial gas distributors in Los Angeles,
CA. The acquired company generates approximately $4.5 million in annual sales, and has five retail locations across the Los Angeles
metro market. The acquired company also sells industrial gases and welding supply products into the Mexican markets in Baja California
and Sonora, through a relationship with one of the largest independent industrial gas operators in the region. The transaction
was structured as an asset purchase, with a cash purchase price of $2.5 million.
This
transaction effectively completes the initial phase and business objectives of the Company's acquisition program initiated
in early 2017. These objectives were originally as follows:
●
Establish
a top five independent industrial gas business in the two largest industrial gas markets in the United States
●
Generate
sufficient customer interest to support new Taronis production facilities in East Texas, Northern California and Southern
California
●
Leverage
our proprietary, patented technology to grow our market position to at least $100 million in approximately five years
●
Establish
a clear operational vision supporting the ability to further grow each market to at least $100 million within approximately
ten years, and selectively expand the regional footprint to support a combined $250 million US industrial gas business
●
Increase
the Company's revenue base to a level that creates a clear and imminent path to cash flow positive operations
●
Expand
the Company's access to capital, particularly the bank debt markets, to effectively leverage our balance sheet and enhance
the potential return on equity for shareholders
●
Leverage
that platform of financial scale and stability to fund international expansion, to fund further research and development for
renewable fuel products, and to launch a scalable water decontamination business
"This
acquisition is the final milestone in first phase of our initial business plan set forth in early 2017", commented Scott
Mahoney, Chief Executive Officer of Taronis Technologies. "Two years ago, our Board established a series of business objectives.
This plan required making a series of carefully selected acquisitions in California and Texas that would enable our Company to
become a top five independent competitor in the most attractive markets in the US today for industrial gases. With this transaction,
we have completed that critical goal".
Mr.
Mahoney continued, "After completing nine acquisitions in the past thirteen months, we have increased our revenue run rate
by approximately 800%, and believe that we can now reduce our acquisition rate. Our goal was to quickly reach a scale that could
sustainably fund our research and development efforts, our corporate overhead, and create a largely self-funded business model.
We chose to take this path because we felt it would be a much more cost effective and efficient method of penetrating extremely
competitive markets as compared to a much slower, more costly path through organic expansion. And as a result, we accomplished
in a little over one year what could have taken more than twenty years to do organically".
Mr.
Mahoney concluded, "We are now able to shift much of our operational focus to the deployment of our metal cutting fuel production
capabilities across Texas and California. Our goal is to convert all of our traditional metal cutting fuel clients to our patented
MagneGas metal cutting fuel product. We produce the only renewable metal cutting fuel in the world, and believe it is a vastly
superior product. We believe in our cleaner, safer, smarter solution, and we intend to aggressively demonstrate these benefits
to our clients and the broader market in 2019 and beyond".
About
Taronis Technologies, Inc.
Taronis
Technologies, Inc. (TRNX) owns a patented plasma arc technology that enables two primary end use applications for fuel generation
and water decontamination.
The
Company's fuel technology enables a wide use of hydrocarbon feedstocks to be readily converted to fossil fuel substitutes.
The Company is developing a wide range of end market uses for these fuels, including replacement products for propane, compressed
natural gas and liquid natural gas. The Company currently markets a proprietary metal cutting fuel that is highly competitive
with acetylene. The Company distributes its proprietary metal cutting fuel through Independent Distributors in the U.S and through
its wholly owned distributors: ESSI, Green Arc Supply, Paris Oxygen, Latex Welding Supplies, Tyler Welders Supply, United Welding
Supplies, Trico Welding Supply and Complete Welding of San Diego. The Company operates 17 locations across California, Texas,
Louisiana, and Florida.
The
Company's technology can also be implemented for the decontamination of waste water, including sterilizing water, eradicating
all pathogens. The technology is being tested to determine if it can completely eliminate pharmaceutical contaminants such as
antibiotics, hormones and other soluble drugs suspended in contaminated water. Lastly, the technology process is capable of reducing
or eliminating other contaminants, such as harmful metals, as well as nitrogen, phosphorus, and potassium levels that trigger
toxic algae blooms. The technology has prospective commercial applications in the agricultural, pharmaceutical, and municipal
waste markets. For more information on Taronis, please visit the Company's website at
http://www.TaronisTech.com
.
FORWARD-LOOKING
STATEMENTS
This
press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability
to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors
that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future
results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should
not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors
which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity,
performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject
to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and
liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update
the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information
becomes available in the future.
For
a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public
filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.

text: Taronis

text: Taronis

text: Taronis Technologies, Inc.

text: Taronis

text: Taronis

text:
Scott
Mahoney

text: Taronis Technologies, Inc.

text:
Taronis
Technologies, Inc.

text: Taronis


text:
EX-99.1
2
exh99-1.txt
PR
EXHIBIT 99.1
PRESS RELEASE
AUSTRALIAN-CANADIAN OIL ROYALTIES LTD. (OTCBB: AUCAF)
ACOR ANNOUNCES CLOSING OF SURAT BASIN ASSETS, SECOND TRANCHE OF FINANCING AT
$0.35 PER SHARE AND PROVIDES CORPORATE UPDATE
FOR IMMEDIATE RELEASE
CISCO, TX, MARCH 1, 2012 -Australian-Canadian Oil Royalties Ltd. (OTCBB: AUCAF)
("ACOR" or the "Company") is pleased to announce the closing of the acquisition
of working interests in the Surat basin, onshore Australia, as previously
announced on November 21, 2011. The Company is also pleased to announce the
closing of the second tranche of financing at US$0.35 per share and provide
guidance on current and future operations in Australia.
HIGHLIGHTS
o Acquisition of a 100% working interest in 4 oilfields with
independently estimated remaining recoverable resources between 3.8
million barrels and 6.6 million barrels(1).
o Acquisition of a 50% working interest in 1 oilfield with independently
estimated remaining recoverable resources of 100,000 barrels net to
the Company1
o Closing of two financings for gross total proceeds of approximately
US$1.915 million
o Addition of Bill Petrie Sr. and Jesse Meidl to the Company's Board of
Directors, and retirement of Robert Kamon from the Company's Board of
Directors
(1) Per report dated August 2007 by CDS Data Services Pty Ltd.
SURAT BASIN ACQUISITION - SIGNIFICANT REMAINING RECOVERABLE OIL
ACOR has acquired a 100% working interest in PL 18, PL 40, and a 50% working
interest in PL 280 are located in the Bowen/Surat Basin in Queensland Australia.
This basin was home to the first oil discovery in Australia, and is currently
the focus of significant coal-seam gas exploration and production activity by
others.
The assets acquired by ACOR include 5 oilfields: Yellowbank Creek, Thomby Creek,
Louise, McWhirter, Narrows and Beardmore. These fields were developed in the
1970's and 1980's, and have collectively produced approximately 7-10% of the
estimated oil originally in place ("OOIP"). ACOR believes that up to 50% of the
OOIP is potentially recoverable through the application of well-established
enhanced recovery techniques including downspacing, horizontal drilling, and
reservoir pressure maintenance through waterflooding.
-1-
In 2007, the vendors of the Surat assets (the "Vendors") obtained an independent
resource report by CDS Data Services Pty Ltd. ("CDS Report") to assess the
remaining recoverable oil resources in the 5 fields. The CDS Report provided a
range of 3.8 million barrels of oil equivalent to 6.7 million barrels of
remaining recoverable oil resources. Since 2007, there has been no significant
investment in the fields as the Vendors were unsuccessful in securing the
necessary capital to develop the remaining oil resources (See "Cautionary
Statements" below). The fields were recently producing 4 barrels of oil per day
(bopd) of high quality 51(degree) oil, which is sold at a premium of
approximately US$8.50 above Brent crude oil price, or a premium of approximately
US$24.00 above West Texas Intermediate crude oil price.
POST-CLOSING ACOR CAPITAL STRUCTURE
Post-closing, ACOR currently has 50,000,000 shares issued and outstanding. ACOR
has agreed to hold an annual and special meeting of shareholders as soon as
practicable, in order to, among other things, amend the authorized share capital
of the Company to provide for an unlimited number of shares. Upon such
amendments taking effect and in accordance with the terms of the share exchange
agreement dated November 17, 2011 (the "Share Exchange Agreement") among ACOR,
1629518 Alberta Ltd. and certain other parties thereto, the Company will issue
an additional 69,065 shares of the Company to Bill Petrie Sr, Bill Petrie Jr,
and Jesse Meidl, along with the issuance of 5,000,000 Share Purchase Warrants of
ACOR (the "Warrants") to certain persons in accordance with the Share Exchange
Agreement. The Warrants will have a strike price of US$0.25 per share, and will
only vest if the Company trades at a price above US$1.00 per share for 10
consecutive days, with a total of 100,000 ACOR shares trading during the 10 day
period, and expire 24 months after closing.
The Company has agreed to pay the Vendors US$3.0 million within 12 months of the
closing of the Acquisition (the "Deferred Consideration"). The Vendors have
secured a first lien over PL 18, PL 40, and PL 280. The Company intends to
secure a reserve based lending facility to refinance the Deferred Consideration,
which does not accrue interest or other charges within 12 months of closing.
NEW DIRECTORS
The Board of ACOR are pleased to add two experienced oil industry executives:
William Petrie Sr. and Jesse Meidl.
Mr. Petrie has in excess of 35 years' experience as a petroleum geologist,
primarily in Western Canada. He began his career with Mobil Oil, leaving after
several years to join the independent sector. He has been involved as President
and Director for a number of public and private oil and gas companies. In these
positions he was responsible for generating, evaluating, and successfully
exploiting oil and gas exploration, development, and acquisition opportunities
throughout North America.
-2-
Mr. Meidl has over 15 years of experience in the oil and gas sector. He is Chief
Financial Officer of a private international energy company, headquartered in
London, England. Prior thereto, he was an investment banker in the International
Oil & Gas group of Thomas Weisel Partners in London (Now Stifel Nicolas). Mr.
Meidl was previously the Chief Financial Officer for Arsenal Energy Inc., an
international exploration company listed on the Toronto Stock Exchange, which
held production assets in Canada and the USA and exploration assets in Egypt,
Colombia and Uzbekistan. He qualified as a Chartered Accountant with KPMG in
Calgary, where he specialized in oil and gas exploration and production and
services. He also holds the ICAEW Corporate Finance qualification and a B. Comm.
degree from the University of Saskatchewan (Canada).
The Company also advises that Robert Kamon has retired from the Board, and has
also relinquished his duties as Corporate Secretary. Mr. Kamon was a co-founder
of ACOR and through his efforts and service led the Company to its vast oil and
gas holdings in Australia. The Board of Directors further acknowledges that his
contributions to the Company will be missed.
CORPORATE UPDATE
In the second quarter of 2012, the Company will be undertaking a workover
program of certain wells on PL 40 and PL 280 which will reactivate two old wells
at a cost of A$400,000. The workover program is anticipated to bring total field
production to approximately 25 barrels of oil per day.
The Company will also be obtaining an updated reserve and resource report over
all of the assets in the Company's portfolio, including the Surat basin assets
and ACOR's ATP 582 in the Georgina basin. It is anticipated the report will be
finalized in the second quarter of 2012.
CAUTIONARY STATEMENTS
Certain statements in this material may be "forward-looking statements"
including outlook on oil and gas prices, estimates of future production,
estimated completion dates of acquisitions and construction and development
projects, business plans for drilling and exploration, estimated amount and
timing of capital expenditures and anticipated future debt levels and royalty
rates. Information concerning reserves contained in this material may also be
deemed forward-looking statements as such estimates involve the implied
assessment that the resources described can be profitably produced in the
future. These statements are based on current expectations, estimates and
projections that involve a number of risks and uncertainties, which could cause
actual results to differ from those anticipated by ACOR.
Statements contained in this press release and corporate information relating to
future results, events and expectations are forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended and Section
21E of the Securities Exchange Act of 1934, as amended. These forward-looking
statements involve known and unknown risks, uncertainties, scheduling,
re-scheduling and other factors which may cause the actual results, performance,
estimates, projections, resource potential and/or reserves, interpretations,
prognoses, schedules or achievements of the Corporation, or industry results, to
be materially different from any future results, performance or achievements
expressed or implied by such statements. Such factors include, among others,
those described in the Corporations' annual reports on Form 40-F or Form 20-F on
file with the U.S. Securities and Exchange Commission ("SEC").
-3-
Users are cautioned that these values represent resources, and not reserves as
defined by the SEC. Under SEC standards, mineralization may not be classified as
a reserve unless the determination has been made that the mineralization could
be economically and legally produced or extracted at the time the reserve
determination is made. Mineral resources that are not mineral reserves do not
have demonstrated economic viability. Investors are cautioned not to assume that
all of measured or indicated resources will ever be converted into reserves.
We seek safe harbor.
For further information on ACOR, please visit our website at www.aussieoil.com,
e-mail acorltd@suddenlink.net or call:
1-254-442-2638 (Office)
1-800-290-8342 (Toll Free in the United States)
-4-

text: AUSTRALIAN-CANADIAN OIL ROYALTIES LTD.

text: ACOR

text: Australian-Canadian Oil Royalties Ltd.

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR

text: ACOR


text:
EX-99
5
oakridgeglobalenergysolution.htm
PRESS RELEASE DATED DECEMBER 11, 2014
Oakridge Global Energy Solutions Announces Execution of Letter of Intent to Acquire Controlling Interest in Leclanché SA
Oakridge Global Energy Solutions Announces Execution of Letter of Intent to Acquire Substantial Interest in Leclanché S.A.
MELBOURNE, Fla.--(BUSINESS WIRE)--Dec. 11, 2014--Oakridge Global Energy Solutions, Inc. (OTC: OGES), a cutting-edge technological leader in solid-state battery systems, today announced the execution of a binding Letter of Intent to acquire controlling interest in Leclanché S.A., a Swiss share company.
Under the terms of the agreement, Oakridge will acquire from Precept Fund Management SPC 11,000,000 shares of Leclanché. Traded on the SIX Swiss Exchange, the value of the transaction was estimated at approximately $45 million on December 5, 2014, the date when the Letter of Intent was executed, based solely on the Purchase Price of Leclanché's shares in the Letter of Intent rather than the higher quoted price for such shares.
"We at Precept are very excited with the enormous growth potential of Oakridge based on its focused approach over the past 12 months to its core business of high quality specialist lithium ion prismatic battery manufacturing for both the defense and the civilian markets", said Steve Barber, the Chairman and Chief Investment Officer of the Company's major shareholder, Precept Fund Management SPC. "As a result, we have decided to consolidate all of our strategic Lithium ion battery manufacturing investments under Oakridge from this point on, most especially given the announced plans for Oakridge to move its listing from the OTC BB to the Capital Market of NASDAQ in the near term".
Founded in 1909 in Yverdon-les-Bains, Switzerland, Leclanché S.A. is the company that originally invented the lead acid battery used throughout the world for starter motor batteries, and one of the oldest continuously operating names in the global battery business and is believed to be the largest battery manufacturer in Europe.
Mr. Barber continued, "Having Oakridge step into Precept's shoes as the major shareholder of such an august old battery manufacturing name as Leclanché S.A. will not only enable Oakridge to more directly capitalize on the previously announced strategic alliance between the two companies for Lithium ion technology interchange, by virtue of it being Leclanche's major shareholder and only battery industry shareholder, but will also represent an important strategic industry investment for Oakridge in Leclanché and its new Lithium Titanate energy storage technology and ceramic safety separator technology, with a view to furthering Oakridge's execution of its previously announced industry consolidation "vertical investment" strategy".
Additional information can be accessed in our 8-K Current Report dated December 5, 2014, which was filed with the Securities and Exchange Commission on December 11, 2014.
FORWARD-LOOKING STATEMENT DISCLAIMER
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate", "believe", "continue", "could", "estimate", "expect", "intend", "may", "ongoing", "plan", "potential", "predict", "project", "should", "will", "would", or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the EDGAR Archives of the Securities and Exchange Commission at www.sec.gov.
Press Contacts:
Ben Jackson
ir@oakridgeenergytech.com
213.674.6700

text: Oakridge Global Energy Solutions

text: Leclanché SA

text: Oakridge Global Energy Solutions

text: Leclanché S.A.

text: Oakridge Global Energy Solutions, Inc.

text: Leclanché S.A.

text: Oakridge

label: fund

text: Precept Fund Management SPC

override: fund

text: Leclanché

text: Leclanché

text: Oakridge

text: Precept Fund Management SPC

text: Oakridge

text: Oakridge

text: Leclanché S.A.

text: Oakridge

text: Leclanché S.A.

text: Oakridge

text: Oakridge

text: Leclanché

text: Oakridge


text:
EX-99
2
ex99edison1212.htm
EXHIBIT 99: PRESS RELEASE
ex99edison1212
Exhibit 99
Contact: Roger R. Hopkins, Chief Accounting Officer
Phone: (615) 890-9100
NHI Sells New Jersey Facility For $23 Million
MURFREESBORO, Tenn. - (December 28, 2012) National Health Investors, Inc. (NYSE:NHI) announced today it has sold its 148-bed, Edison, New Jersey senior living campus for $23 million to its current tenant, Sunrise Senior Living, pursuant to a purchase option between the parties. Billed revenue to NHI during 2012 was approximately $1.4 million.
About National Health Investors
National Health Investors, Inc. (NYSE: NHI) is a healthcare real estate investment trust specializing in financing healthcare real estate by purchase and leaseback transactions, RIDEA transactions and by mortgage loans. NHI's investments include independent living, assisted living, senior living campuses, skilled nursing facilities, medical office buildings, and hospitals. Find additional information about NHI at www.nhireit.com.
Statements in this press release that are not historical facts are forward-looking statements. NHI cautions investors that any forward-looking statements may involve risks and uncertainties and are not guarantees of future performance. All forward-looking statements represent NHI's judgment as of the date of this release. Investors are urged to carefully review and consider the various disclosures made by NHI in its periodic reports filed with the Securities and Exchange Commission, including the risk factors and other information disclosed in NHI's Annual Report on Form 10-K for the most recently ended fiscal year. Copies of these filings are available at no cost on the SEC's web site at http://www.sec.gov or on NHI's web site at http://www.nhireit.com.

text: NHI

text: National Health Investors, Inc.

text: NHI

text: Sunrise Senior Living

text: NHI

text: National Health Investors, Inc.

text: NHI

text: NHI

text: NHI

text: NHI

text: NHI

text: NHI

text: NHI

text: NHI